Stiff person syndrome (SPS) is a rare autoimmune neurological disorder that causes progressive muscle stiffness and painful spasms, primarily in the trunk and legs. Prevalence estimates range from one to two cases per 100,000 people down to as few as one per million, and it most commonly appears in a person’s 40s, though onset can occur anywhere between ages 30 and 60.
How SPS Affects the Body
Your muscles normally work in coordinated pairs. When one muscle contracts (say, the biceps), the opposing muscle (the triceps) automatically relaxes. This happens because your nervous system uses an inhibitory chemical messenger called GABA to silence the opposing muscle’s nerve signals while the first muscle fires.
In stiff person syndrome, the immune system produces antibodies that target the enzyme responsible for making GABA. With less GABA available, the nervous system loses its ability to keep opposing muscles relaxed. The result: both muscles in a pair fire at the same time, even at rest. This is what causes the constant stiffness and the intense, sometimes violent spasms that define the condition. Brain imaging studies confirm that people with SPS have reduced GABA levels in both the brain and spinal fluid, and stimulation studies show their motor cortex is abnormally excitable.
What Stiffness and Spasms Feel Like
The hallmark of SPS is a rigid, board-like stiffness that typically starts in the muscles of the lower back and abdomen, then spreads to the legs. This stiffness is constant, not something that comes and goes with activity. Over time it can alter posture, restrict movement, and make walking increasingly difficult. Some people develop a wide, stiff-legged gait, and falls become common.
Layered on top of the stiffness are sudden, powerful muscle spasms. These can be triggered by being startled or surprised, sudden movements, loud or unexpected noises, physical touch, cold temperatures, and emotional stress. Some people find that specific exercises also set off spasms. The spasms can be severe enough to cause falls or injury, and the unpredictability of triggers often leads to significant anxiety, which itself can worsen symptoms.
How SPS Is Diagnosed
Diagnosis typically involves a combination of blood tests, electrical muscle testing, and sometimes a spinal fluid analysis. The process can take time because the condition is so rare that many clinicians have never seen a case.
The most important blood test looks for antibodies against the GABA-producing enzyme (called anti-GAD antibodies). High levels of these antibodies are highly specific for SPS. However, not everyone with SPS tests positive on a standard blood draw. When blood antibody levels are low or absent, a lumbar puncture can be revealing: nearly two-thirds of SPS patients have markers of immune activation in their spinal fluid, and 85% show evidence that their immune system is actively producing these antibodies inside the central nervous system.
Electromyography, a test that measures electrical activity in muscles, shows a characteristic pattern: the motor units in opposing muscles fire continuously, even when the person is trying to relax. This abnormal firing may worsen in response to loud noises and typically improves with medications that boost GABA activity. Normal nerve conduction studies help rule out other conditions that could explain the stiffness.
One important nuance: antibody levels don’t correlate with how severe the disease is. A person with very high antibody levels may have milder symptoms than someone with lower levels. The antibodies serve as a diagnostic marker, not a measure of disease progression.
Conditions That Often Accompany SPS
Because SPS is autoimmune, it frequently appears alongside other autoimmune conditions. Type 1 diabetes is the most common association. Thyroid disease, pernicious anemia, and vitiligo also occur at higher rates in people with SPS. In a small percentage of cases, SPS can be linked to an underlying cancer (paraneoplastic SPS), which involves a different antibody and may require a separate workup.
Treatment and Symptom Management
Treatment for SPS addresses two layers of the problem: the muscle symptoms themselves and the underlying immune dysfunction driving them.
For stiffness and spasms, medications that enhance GABA activity in the nervous system are the first line of defense. These work by partially compensating for the GABA that the body can no longer produce efficiently. Many patients experience meaningful relief from stiffness, though the degree of improvement varies.
For the autoimmune component, immunotherapy aims to calm the overactive immune response. Infusions of pooled antibodies from donors (IVIG) have shown benefit in controlled trials, reducing stiffness and improving daily function. Other immune-suppressing approaches are used when IVIG is insufficient or unavailable, though controlled evidence for some of these is limited. Notably, even when immunotherapy improves symptoms, it doesn’t reliably lower the antibody levels themselves, reinforcing the idea that the disease mechanism is more complex than the antibodies alone.
An Experimental Cell Therapy
A newer approach uses engineered immune cells (CAR T-cells) that target and eliminate the B cells responsible for producing the harmful antibodies. In a Phase II clinical trial of 26 patients, this therapy, called miv-cel, produced striking results. Patients’ walking speed improved roughly four months after treatment, and eight of 12 people who had relied on a walking aid were able to stop using it. The company developing the treatment plans to request FDA approval in the first half of 2026.
Living With SPS
SPS is a chronic condition, and for most people it progresses slowly over years. Without treatment, stiffness tends to worsen and mobility declines. Some people eventually need a cane, walker, or wheelchair. The unpredictability of spasms often reshapes daily life: people may avoid crowded or noisy environments, limit driving, or become increasingly homebound out of fear of triggering an episode.
With treatment, many people achieve significant symptom control and maintain a meaningful degree of independence, though the disease rarely goes into full remission. Physical therapy plays an important supporting role by maintaining flexibility and preventing the postural changes that chronic stiffness can cause. Mental health support also matters, since the anxiety and social withdrawal that accompany SPS can be as disabling as the physical symptoms themselves.